|
|
41
|
4582A
|
BERIATE 500IU INJ (CSL) FACTOR VIII (BQ)
|
10ML VIAL
|
BQ
|
244.6492
|
500IU
|
12
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
4582P
|
HEMOREL A 500IU INJ (RLS/AHI) FACTOR VIII
|
500IU VIAL
|
BQ
|
330.28
|
500IU
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4582P
|
HEMOREL A 500IU INJ (RLS) FACTOR VI (BQ)
|
500IU VIAL
|
BQ
|
305.8115
|
500IU
|
12
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
4582P
|
HEMOREL A 500IU INJ (RLS) FACTOR VI
|
500IU VIAL
|
BQ
|
309.48
|
500IU
|
12
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
4582Q
|
XYNTHA 500IU INJ (PFI) FACTOR VIII (C)
|
500IU VIAL
|
C
|
1065.882
|
500IU
|
12
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
4582T
|
BERIATE 500IU INJ (CSL) FACTOR VIII
|
500IU VIAL
|
BQ
|
244.65
|
500IU
|
12
|
2026-04-01
|
|
No
|
No
|
Add to Contract
|
0
|
|
|
40
|
46121
|
IMOVAX POLIO (AVP/COL) POLIOMYELITIS
|
1 DOSE
|
B
|
24.46
|
80AU
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
46121
|
IMOVAX POLIO (AVP) POLIOMYELITIS
|
1 DOSE
|
B
|
24.4649
|
80AU
|
1
|
2024-04-01
|
2024-10-21
|
|
|
|
0
|
|
|
40
|
4621BC
|
XANAX 0.5MG TAB (PFI/SBI) ALPRAZOLAM
|
100'S
|
C
|
0.47
|
0.5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4621BC
|
XANAX 0.5MG TAB (PFI) ALPRAZOLAM (C)
|
100'S
|
C
|
0.4836
|
0.5MG
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
4621CQ
|
XANAX 0.5MG TAB (PFI) ALPRAZOLAM (C)
|
10X10
|
C
|
0.48
|
0.5MG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
4621L
|
XANAX 0.5MG TAB (PFI/STO) ALPRAZOLAM
|
100'S
|
C
|
0.47
|
0.5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4621L
|
XANAX 0.5MG TAB (PFI) ALPRAZOLAM (C)
|
100'S
|
C
|
0.4836
|
0.5MG
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
4621R
|
APO-ALPRAZ 0.5MG TAB (APO/COL)
|
1000'S
|
A
|
0.04
|
0.5MG
|
30
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
42
|
4621R
|
APO-ALPRAZ 0.5MG TAB (APO)
|
1000'S
|
A
|
0.05
|
0.5MG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
4621V
|
APO-ALPRAZ 0.5MG TAB (APO)
|
1000'S
|
A
|
0.0377
|
0.5MG
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
4622S
|
LORAZEPAM 2MG/ML INJ (KWA/ATB)
|
10X1ML
|
B
|
3.82
|
2MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4622S
|
LORAZEPAM 2MG/ML INJ (KWA) (B)
|
10X1ML
|
B
|
3.0907
|
2MG/ML
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
4622U
|
LORAZEPAM 2MG/ML INJ (FSB/ATB)
|
1ML VIAL
|
B
|
4.02
|
2MG/ML
|
0
|
2022-05-27
|
2024-03-31
|
|
|
Price Change
|
0
|
|
|
40
|
46241
|
APO-ALPRAZ 0.25MG TAB (APO/COL)
|
100'S
|
A
|
0.05
|
0.25MG
|
30
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|